TCRT Insider Transactions
74 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–74; provenance stays internal.
TCRT insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Vieser Jaime | Director | 2024-12-31 | Sale | 818.0 | $2.0 |
| Vieser Jaime | Director | 2024-12-31 | Sale | 2,182.0 | $2.01 |
| Boyle Kevin S. Sr. | Chief Executive Officer | 2023-09-01 | Sale | 68,014.0 | $0.14 |
| Postma Robert W | Director | 2022-11-29 | Purchase | 750,000.0 | $0.65 |
| Vieser Jaime | Director | 2022-11-29 | Purchase | 1,250,000.0 | $0.65 |
| De Groot Eleanor | EVP, Operations | 2021-12-22 | Sale | 20,132.0 | $1.27 |
| Boyle Kevin S. Sr. | Chief Executive Officer | 2021-11-17 | Purchase | 9,116.0 | $1.4 |
| Boyle Kevin S. Sr. | Chief Executive Officer | 2021-11-16 | Purchase | 884.0 | $1.4 |
| Vieser Jaime | Director | 2021-09-29 | Purchase | 100,000.0 | $1.91 |
| Hagen Heidi | Director | 2021-09-02 | Purchase | 23,770.0 | $1.76 |
| Postma Robert W | Director | 2021-09-02 | Purchase | 54,492.0 | $1.73 |
| Postma Robert W | Director | 2021-09-02 | Purchase | 20,508.0 | $1.73 |
| Weis Holger | Director | 2021-09-01 | Purchase | 50,000.0 | $1.83 |
| Huang James | Director | 2021-09-01 | Purchase | 100,000.0 | $1.71 |
| Buck Jill | EVP, GM Gene Therapy | 2021-01-08 | Sale | 27,894.0 | $3.12 |
| Lafond Kevin G | SVP, Treasurer & CAO | 2021-01-08 | Sale | 18,020.0 | $3.09 |
| Hadfield Robert | General Counsel and Secretary | 2021-01-08 | Sale | 26,500.0 | $3.12 |
| De Groot Eleanor | EVP, GM Cell Therapy | 2021-01-04 | Sale | 21,620.0 | $2.72 |
| Cooper Laurence James Neil | President and CEO | 2021-01-04 | Sale | 105,693.0 | $2.71 |
| MAUNEY DAVID M MD | President | 2020-01-02 | Sale | 22,394.0 | $4.55 |
| Lafond Kevin G | SVP, Treasurer & CAO | 2020-01-02 | Sale | 21,570.0 | $4.55 |
| Hadfield Robert | General Counsel and Secretary | 2020-01-02 | Sale | 16,853.0 | $4.55 |
| De Groot Eleanor | EVP, GM Cell Therapy | 2020-01-02 | Sale | 24,890.0 | $4.55 |
| Buck Jill | EVP, GM Gene Therapy | 2020-01-02 | Sale | 27,923.0 | $4.55 |
| Cooper Laurence James Neil | Chief Executive Officer | 2019-12-30 | Sale | 110,694.0 | $4.88 |
| Lafond Kevin G | SVP, Treasurer & CAO | 2019-11-26 | Sale | 11,667.0 | $5.25 |
| Cooper Laurence James Neil | Chief Executive Officer | 2017-11-08 | Purchase | 6,440.0 | $4.68 |
| MAUNEY DAVID M MD | EVP and Chief Business Officer | 2017-11-08 | Purchase | 4,270.0 | $4.68 |
| BELBEL CAESAR J | COO, CLO, and Secretary | 2015-11-19 | Sale | 153,333.0 | $12.84 |
| LEBEL FRANCOIS | Executive Vice President R&D | 2015-06-09 | Sale | 50,000.0 | $10.12 |
| BRENNAN MURRAY | Director | 2015-06-04 | Sale | 5,837.0 | $9.55 |
| Lafond Kevin G | Vice Pres., Treasurer, & CAO | 2015-06-03 | Sale | 27,500.0 | $9.7 |
| Lafond Kevin G | Vice Pres., Treasurer, & CAO | 2015-06-03 | Sale | 3,334.0 | $9.7 |
| Lafond Kevin G | Vice Pres., Treasurer, & CAO | 2015-06-03 | Sale | 26,666.0 | $9.6 |
| BRENNAN MURRAY | Director | 2015-06-03 | Sale | 34,163.0 | $9.72 |
| KIRK RANDAL J | Director,TenPercentOwner | 2015-02-09 | Purchase | 1,440,000.0 | $8.75 |
| INTREXON CORP | TenPercentOwner | 2015-02-09 | Purchase | 1,440,000.0 | $8.75 |
| KIRK RANDAL J | Director,TenPercentOwner | 2013-10-29 | Purchase | 2,857,143.0 | $3.5 |
| INTREXON CORP | TenPercentOwner | 2013-10-29 | Purchase | 2,857,143.0 | $3.5 |
| KIRK RANDAL J | Director,TenPercentOwner | 2012-11-07 | Purchase | 3,636,926.0 | — |
| INTREXON CORP | TenPercentOwner | 2012-11-07 | Purchase | 3,636,926.0 | — |
| KIRK RANDAL J | Director,TenPercentOwner | 2012-01-20 | Purchase | 1,923,075.0 | $5.2 |
| INTREXON CORP | TenPercentOwner | 2012-01-20 | Purchase | 1,923,075.0 | $5.2 |
| KIRK RANDAL J | Director,TenPercentOwner | 2011-08-23 | Purchase | 38,294.0 | $4.99 |
| INTREXON CORP | TenPercentOwner | 2011-08-23 | Purchase | 38,294.0 | $4.99 |
| KIRK RANDAL J | Director,TenPercentOwner | 2011-08-22 | Purchase | 110,792.0 | $4.91 |
| INTREXON CORP | TenPercentOwner | 2011-08-22 | Purchase | 110,792.0 | $4.91 |
| KIRK RANDAL J | Director,TenPercentOwner | 2011-08-19 | Purchase | 197,376.0 | $4.91 |
| INTREXON CORP | TenPercentOwner | 2011-08-19 | Purchase | 197,376.0 | $4.91 |
| KIRK RANDAL J | Director,TenPercentOwner | 2011-08-18 | Purchase | 153,478.0 | $4.95 |
| INTREXON CORP | TenPercentOwner | 2011-08-18 | Purchase | 153,478.0 | $4.95 |
| Fowler Wyche | Director | 2011-08-10 | Purchase | 5,000.0 | $5.19 |
| KIRK RANDAL J | Director,TenPercentOwner | 2011-08-09 | Purchase | 285,518.0 | $5.13 |
| INTREXON CORP | TenPercentOwner | 2011-08-09 | Purchase | 285,518.0 | $5.13 |
| KIRK RANDAL J | Director,TenPercentOwner | 2011-08-08 | Purchase | 444,892.0 | $4.58 |
| INTREXON CORP | TenPercentOwner | 2011-08-08 | Purchase | 444,892.0 | $4.58 |
| KIRK RANDAL J | Director,TenPercentOwner | 2011-08-05 | Purchase | 116,112.0 | $4.65 |
| INTREXON CORP | TenPercentOwner | 2011-08-05 | Purchase | 116,112.0 | $4.65 |
| WEISER MICHAEL | Director | 2011-05-25 | Sale | 15,000.0 | $6.53 |
| BRENNAN MURRAY | Director | 2011-05-09 | Sale | 15,000.0 | $6.57 |
| KIRK RANDAL J | Director,TenPercentOwner | 2011-02-03 | Purchase | 1,910,000.0 | $5.75 |
| INTREXON CORP | TenPercentOwner | 2011-02-03 | Purchase | 1,910,000.0 | $5.75 |
| KIRK RANDAL J | Director,TenPercentOwner | 2011-01-12 | Purchase | 3,636,926.0 | — |
| INTREXON CORP | TenPercentOwner | 2011-01-12 | Purchase | 3,636,926.0 | — |
| KIRK RANDAL J | Director,TenPercentOwner | 2011-01-12 | Purchase | 2,426,235.0 | $4.8 |
| INTREXON CORP | TenPercentOwner | 2011-01-12 | Purchase | 2,426,235.0 | $4.8 |
| CANNON JAMES ANTHONY | Director | 2009-12-09 | Purchase | 175,000.0 | $3.1 |
| MCINERNEY TIMOTHY | Director | 2009-12-09 | Purchase | 50,000.0 | $3.1 |
| ESSEX WOODLANDS HEALTH VENTURES FUND VI L P | TenPercentOwner | 2009-12-08 | Purchase | 129,000.0 | $3.1 |
| ESSEX WOODLANDS HEALTH VENTURES FUND VI L P | TenPercentOwner | 2009-09-15 | Purchase | 328,766.0 | $1.83 |
| MCINERNEY TIMOTHY | Director | 2009-09-15 | Purchase | 50,000.0 | $1.83 |
| LEWIS JONATHAN | CEO | 2007-12-07 | Purchase | 3,000.0 | $3.0 |
| MCINERNEY TIMOTHY | Director | 2007-03-15 | Purchase | 4,000.0 | $5.0 |
| LEWIS JONATHAN | CEO | 2007-03-12 | Purchase | 2,000.0 | $4.95 |